biperiden has been researched along with Aura in 3 studies
Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We assessed in a follow-up study of 4 years (medium, range: 2-7 years) the usefulness of the antiparkinsonian drug biperiden (Akineton©), an acetylcholine antagonist with high affinity for muscarinic M1-type receptors, in four consecutive cases of arousal disorder with sleepwalking and confusional behavior in adolescents and adults with or without epilepsy who did not respond to diazepam, clonazepam or amitriptyline." | 9.16 | Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations. ( Hodoba, D; Schmidt, D, 2012) |
| "We assessed in a follow-up study of 4 years (medium, range: 2-7 years) the usefulness of the antiparkinsonian drug biperiden (Akineton©), an acetylcholine antagonist with high affinity for muscarinic M1-type receptors, in four consecutive cases of arousal disorder with sleepwalking and confusional behavior in adolescents and adults with or without epilepsy who did not respond to diazepam, clonazepam or amitriptyline." | 5.16 | Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations. ( Hodoba, D; Schmidt, D, 2012) |
| " She had been diagnosed with idiopathic epilepsy and was given phenytoin 2 months before admission to our hospital." | 3.72 | Use of biperiden hydrochloride in a child with severe dyskinesia induced by phenytoin. ( Anlar, O; Caksen, H; Odabaş, D, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bittencourt, S | 1 |
| Ferrazoli, E | 1 |
| Valente, MF | 1 |
| Romariz, S | 1 |
| Janisset, NRLL | 1 |
| Macedo, CE | 1 |
| Antonio, BB | 1 |
| Barros, V | 1 |
| Mundim, M | 1 |
| Porcionatto, M | 1 |
| Aarão, MC | 1 |
| Miranda, MF | 1 |
| Rodrigues, AM | 1 |
| de Almeida, AG | 1 |
| Longo, BM | 1 |
| Mello, LE | 1 |
| Hodoba, D | 1 |
| Schmidt, D | 1 |
| Caksen, H | 1 |
| Odabaş, D | 1 |
| Anlar, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Biperiden for Prevention of Epilepsy in Patients With Traumatic Brain Injury[NCT04945213] | Phase 3 | 312 participants (Anticipated) | Interventional | 2023-01-10 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for biperiden and Aura
| Article | Year |
|---|---|
Biperiden for treatment of somnambulism in adolescents and adults with or without epilepsy: clinical observations.
Topics: Adolescent; Adult; Biperiden; Cholinergic Antagonists; Epilepsy; Humans; Male; Middle Aged; Polysomn | 2012 |
2 other studies available for biperiden and Aura
| Article | Year |
|---|---|
Modification of the natural progression of epileptogenesis by means of biperiden in the pilocarpine model of epilepsy.
Topics: Action Potentials; Animals; Autonomic Nervous System; Biperiden; Chronic Disease; Cytokines; Disease | 2017 |
Use of biperiden hydrochloride in a child with severe dyskinesia induced by phenytoin.
Topics: Anticonvulsants; Biperiden; Child, Preschool; Dyskinesia, Drug-Induced; Electroencephalography; Epil | 2003 |